Latest News

Digitisation Is Fundamental To Unlocking A Patient-Centric Industry

The fallout of the pandemic coupled with economic uncertainty has left the life sciences and healthcare sectors more stretched than ever, from pharmaceutical manufacturers to healthcare practitioners on the front line with patients. The industry and its workforce are faced with the challenge of meeting new expectations for the faster development and roll out of new medicines, all while demand for care steadily increases and the global population ages. While this provides a distinctly challenging backdrop, there are levers which can be pulled to ease the strain currently faced and unlock a new path to growth for the sector - if they can be implemented effectively. Digitisation – from digital treatments and therapies, all the way to launching research labs in the metaverse – needs to be


Collaboration enables doctors at the hospital to access C37’s fully equipped medical co-working spaces Canadian Specialist Hospital will allow surgeons registered with C37 to perform surgeries within its state-of-the-art operating rooms C37, the UAE’s first private medical co-working space, managed and operated by

Dementia vaccines: What are they, and when could they become available?

Vaccines are arguably one of the greatest inventions of medical science of all time. Now, researchers are looking to take vaccine technology one step further to protect against neurodegenerative diseases like dementia. In this Special Feature, we asked experts about what is currently under development, how a dementia vaccine would work, and how quickly we may see one becoming available to the public. Dementia is an umbrella term referring to a range of disorders that affect the way in which a person’s brain works, causing symptoms including memory loss, behavior changes, and difficulty speaking and walking. The most common form of dementia is Alzheimer’s disease, which accounts for 60% to 80% of dementia cases. More than 55 million people around the world have dementia, with about 10

‘Goldilocks zone’: UC Researchers Seek to Improve Emergency Care

Venture Lab-backed startup develops device to help provide rescue breathing. Technology from a University of Cincinnati Venture Lab-backed startup could save lives by allowing emergency medical personnel to accurately monitor the life-saving treatment they provide. The startup, Spiritus, was founded by three UC
Medical Equipment

The Rise of Wearables: The Future of The Mobile Health Market

According to GlobalData, the wearable technology market was worth nearly $27B in 2019 and is expected to grow by 24.6% each year between 2020 and 2024 to reach $156B. GlobalData’s Internet of Things (IoT) – Thematic Research report suggests that wearable devices are expected to play a significant role in the medical

How do Anesthesia Machines Work?

Imagine going under surgery without anesthesia. Undoubtedly, fear among patients scheduled for surgical procedures is pervasive. Some professionals even attribute patient anxiety to the fear of the anesthetic itself but understanding how doctors administer anesthesia can be incredibly beneficial to easing the tension
Product Focus

MIT Engineers Design a Soft, Implantable Ventilator

The new design works with the diaphragm to improve breathing. For many of us, the act of breathing comes naturally. Behind the scenes, our diaphragm — the dome-shaped muscle that lies just beneath the ribcage — works like a slow and steady trampoline, pushing down to create a vacuum for the lungs to expand and draw air

Redhill Biopharma Ltd Announces Redhill's RHB-102 Positive MHRA Meeting & MAA Plan

RedHill Announces Positive MHRA Meeting and Planned UK Marketing Authorization Application of RHB-102 (BEKINDA®) for Oncology Support UK MHRA scientific advice meeting deems RHB-102 (BEKINDA®) data supportive of submission for approval for chemotherapy and radiotherapy induced nausea and vomiting (CINV/RINV) RHB-102 UK Marketing Authorization Application (MAA) submission planned for 2H/23. If approved for marketing by the MHRA, RHB-102 could become the first oral 24hr extended-release 5-HT3 antiemetic drug in the UK indicated for the treatment of CINV/RINV

Study Uncovers a Previously Unknown Propofol Effect in Neurons

Propofol is the most used drug to induce general anesthesia. Despite its frequent clinical application, it is poorly understood how propofol causes anesthesia. In a new study published in Molecular Biology of the Cell, a team of Rensselaer Polytechnic Institute researchers identified a previously unknown propofol
Campaigns & Recent Studies

Combating Severe Cancer with A New Drug Delivery System

Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with the development of a new cure for cancers that have spread to the peritoneal cavity. It is a spin-off from SINTEF, where the technology was developed over a period of more than ten years within nanomedicine research. The work from which NaDeNo has evolved started in 2012. Initial research at SINTEF yielded promising results, and now both the technology and its patents are being spun off from the research institute and into a separate company. The technology makes it possible to embed large volumes of an active cancer drug in nanoparticle carriers. These carriers are then injected into

How can AI Improve Mental Health for 100 million People?

Mental health matters. According to the World Health Organization, (WHO) 1 in 8 people in the world live with some form of mental health disorder. AI for Good’s recent AI for Health Discovery webinar explored an important question and use case on the application of Artificial Intelligence: How can AI improve mental

PT027 Recommended by FDA Advisory Committee as New Rescue Treatment for Asthma

PT027 is a potential first-in-class, pressurized metered-dose inhaler (pMDI), fixed-dose combination rescue medication in the US containing albuterol, a short-acting beta2-agonist (SABA), and budesonide, an anti-inflammatory inhaled corticosteroid (ICS). It is being developed by AstraZeneca and Avillion. In the first
Diet & Nutrition

The “Medical Bypass”: New Drugs to Strike Obesity

The FDA has granted Mounjaro, drug that showed comparable potential to gastric bypass surgery, a Fast Track designation to treat obesity. In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. In October, the US FDA granted Eli Lilly’s Mounjaro (tirzepatide) a Fast Track designation for its use as a treatment for obesity. The drug was approved to treat type 2 diabetes mellitus in May. Mounjaro is the first weight loss drug to show efficacy rates comparable to surgical procedures like sleeve gastrectomies. Several other treatments, like Novo Nordisk’s CagriSema (semaglutide + cagrilintide), are expected to follow after showing encouraging Phase II data. The UK and US

Nutrabolt Partners with Biotech AI Leader Nuritas to Launch Testosterone Booster

Human performance company Nutrabolt has launched their new Testosterone Booster supplement named Cellucor P6 Ultimate, powered by Nuritas using the next generation of intelligent ingredients unlocked from nature, using AI. This new product, aimed at men, supports healthy testosterone levels, strength, and endurance,
Country Reports

Dehghani: Iran's Capacity to Benefit from The World's 500-Billion-Dollar Market in The Field of Medical Equipment

Ruhollah Dehghani, Vice President of Science, Technology and Knowledge-Based Economy, during his visit to Indonesia and at the medical equipment forum of this country, which was attended by the head of the International Scientific and Research Agency of Indonesia, a group of managers and activists from the health field of the two countries, from the capacities of the ecosystem Iran's knowledge-based economy for international cooperation in the field of health. Dehghani, in the continuation of his trip to Indonesia, referring to the capacity of international markets for knowledge-based interactions in the field of health, considered the historical companionship of the two countries to be central to continuing cooperation and added: There are extensive cultural commonalities between the two

Philips will continue to deliver hospital equipment to Russia, CEO says.

Dutch health technology company Philips (PHG.AS) will continue to deliver hospital equipment to Russia, despite its war on Ukraine, Chief Executive Officer Roy Jakobs said on Tuesday. "The right to healthcare is universal, and we are part of the system delivering healthcare," Jakobs said at the company's annual

Arab Health anticipates 3,000 companies from 70 countries for its next edition in January

The 2023 edition of Arab Health will return to the Dubai World Trade Centre from 30th January – 2nd February under the show's theme, 'Innovation and Sustainability in Healthcare', the organizers said. Exhibitor companies are also anticipated to rise, increasing from 2,828 to over 3,000 from 70 countries, according to Informa Markets. Arab Health has underscored its position as the epicenter of healthcare trade and reaffirmed its support for global businesses and governments by securing AED2.8 billion worth of healthcare industry-related contracts, according to a GRS Explore Exhibitor Survey during the 2022 edition, which was held in Dubai in January. The exhibition plays an integral role in supporting UAE Government initiatives such as ‘Make it in the Emirates’, a platform for developing